Toxicity of Astatine-211 in the Mouse

Human & Experimental Toxicology

Volumn 7, Issue 6, 1988, Pages 529-534

  Cobb, L M ^a   Harrison, A ^a   Butler, S A ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASTATINE 211; RADIOISOTOPE;

ANIMAL EXPERIMENT; BONE MARROW; FEMALE; GONAD; HISTOLOGY; HISTOPATHOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE; MALE; MOUSE; NONHUMAN; SALIVARY GLAND; STOMACH; THYROID GLAND; TOXICITY;

ANIMALIA;

EID: 84973848911     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/096032718800700602     Document Type: Article

References (28)

1. Bloomer W.D. McLaughlin W.H. Lambrecht R.M. et al. 211 At radiocolloid therapy: further observations and comparison with radiocolloids of 32P, 165Dy, and 90Y. International Journal of Radiation Oncology, Biology and Physics. 1984: 10: 341-348.
2. Cobb L.M. Harrison A., Dudley N. et al. Relative uptake of astatine-211 and iodine-125 by human fetal thyroid and human carcinoma of the thyroid in nude mice. Radiotherapy and Oncology, in press.
3. Cobb L.M. & Humm J.A. Radioimmunotherapy of malignancy using antibody targeted radionuclides. British Journal of Cancer 1986; 54: 863-870.
4. Kozak R.W. Atcher R.W. Gansow D.A. et al. Bismuth-212-labelled anti-Tac monoclonal antibody α-particle-emitting radionuclides as modalities for radioimmunotherapy. Proceedings of the National Academy of Sciences of the USA 1986; 83: 474-478.
5. Mitchell J.S. Brown I. & Carpenter R.N. α-Particle track autoradiographic study of the distribution of a [211 At]-astatinated drug in normal tissue of the mouse. Experientia 1985; 41: 925-928.
6. Vaughan Atm, Bateman W.J. & Fisher D.R. The in vivo fate of a 211 At labelled monoclonal antibody with known specificity in a murine system. International Journal of Radiation Oncology, Biology and Physics 1982; 8: 1943-1946.
7. Humm J.L. Dosimetric aspects of radiolabeled antibodies for tumour therapy. Journal of Nuclear Medicine 1986; 27: 1490-1497.
8. Urtasun R.C. Chapman J.D. Raleigh J.A. et al. Binding of 3H-misonidazole to solid human tumors as a measure of tumor hypoxia. International Journal of Radiation Oncology, Biology and Physics 1986; 12: 1263-1267.
9. Hamilton J.G. Durbin P.W. & Parrott M.W. Comparison of acute and chronic changes produced in rats by iodine-131 and astatine-211 at lethal levels. Preliminary clinical data on the uptake of astatine-211 patients with thyroid disease. Medical and Physiological Applications, Volume 1. Proceedings of the second conference, Oxford, 19-23 July, ed. J.E. Johnston, pp. 219-231. London: Butterworths Scientific Publications, 1954.
10. Hamilton J.G. Asling C.W. Garrison W.M. et al. The accumulation, metabolism and biological effects of astatine in rats and monkeys. University of California Publications in Pharmacology 1953; 2: 283-343.
11. Hamilton J.G. Durbin P.W. Asling C.W. et al. Physiological and biochemical studies of astatine-211 (Eka-Iodine). Proceedings of the International Conference on the Peaceful Use of Atomic Energy, Geneva, 1955; volume 10, pp. 175-181. New York, United Nations, 1956.
12. Hamilton J.G. & Soley M.H. A comparison of the metabolism of iodine and of element 85 (eka-iodine). Proceedings of the National Academy of Sciences of the USA 1940; 26: 483-489.
13. Harrison A. & Royle L. Determination of absorbed dose to blood, kidneys, testes and thyroid in mice injected with 211 At and comparison of testes mass and sperm number in X-irradiated and 211 At treated mice. Health Physics 1984; 46: 377-383.
14. Corson D.R. Mackenzie K.R. & Segré E. Artificially radioactive element 85. Physical Review 1940; 58: 672-678.
15. Jardine L.J. Decays of 211 At, 211 Po and 207 Bi. Physical Review C 1975; 11: 1385-1391.
16. Sims H.E. 211 At and 90 Y: two nuclides for potential use in tumour therapy-production at Harwell Laboratory, AERE, R12209, 1986.
17. Harrison A. & Moore P.C. Loss of mouse testis mass after X-irradiation or injection of 22Na. Health Physics 1980; 38: 1-9.
18. Harrison A. & Moore P.C. Reduction in sperm count and increase in abnormal sperm in the mouse following X-irradiation or injection of 22Na. Health Physics 1980; 39: 219-224.
19. Handelsman D.J. Conway A.J. Donnelly P.E. et al. Azoospermia after iodine-131 treatment for thyroid carcinoma. British Medical Journal 1980; 281: 1527.
20. Stevens L.C. King G.K. Peters L.J. et al. Unique radio-sensitivity of serous cells in Rhesus monkey submandibular glands. American Journal of Pathology 1986; 124: 479-487.
21. Kashima H.K. Kirkham W.R. & Andrews, J.R. Postirradiation sialoadenitis. American Journal of Roentgenology 1965; 94: 271-292.
22. Glucksmann A. & Cherry C.R. Effects of radiation on salivary glands. In Pathology of Irradiation, ed. C.C. Berdjis, pp. 290-295. Baltimore: Williams and Wilkins Company, 1971.
23. Kohn H.I. Kallman R.F. Berdjis C.C. et al. Late effects of whole body X-irradiation in the mouse. Radiation Research 1957; 7: 407-435.
24. Durbin P.W. Asling C.W. Johnston M.E. et al. The induction of tumors in the rat by astatine-211. Radiation Research 1958; 9: 378-397.
25. Binhammer R.T. Finerty J.C. Schneider M., et al. Tumour induction in rats by single total-body X-irradiation. Radiation Research 1957; 6: 339-348.
26. Shellabarger C.J. Cronkite E.P. Bond V.P. et al. The occurrence of mammary tumours in the rat after sublethal whole-body irradiation. Radiation Research 1957; 6: 501-512.
27. Burrow H. & Horning E.S. Estrogens and Neoplasia, Springfield, Illinois: Charles C. Thomas, 1952.
28. Chen T.T. Johnson R.E. Lyons W.R. et al. Hormonally induced mammary growth and lactation in the absence of the thyroid. Endocrinology 1955; 57: 153-157.